Publications

It will come as no surprise to anyone in the digital pathology space that Philips has been transforming the digital pathology market from several directions. Of course, the company completed a non-inferiority study which has been published in...

Although a surgeon’s goal is to remove cancer in its entirety during excision surgery, achieving negative margins (absence of cancer cells at the outer edge of the excised tumor specimen) can be challenging. To facilitate intraoperative...

Last month the FDA approved pembrolizumab (KEYTRUDA) for adult and pediatric patients with with metastatic or unresectable, microsatellite instability-high (MSI-H) or mismatch repair deficient (dMMR) solid tumors that have...

With the ink dry about a month on the recent FDA approval of Philips Intellisite Pathology Solution (PIPS) for primary diagnosis, I came across this headline and others like it last week. Well known, respected pathologists and pathology...

Much is being said, written and discussed about the recent FDA clearance for Philips digital pathology solution for primary surgical pathology diagnosis. Of course, this means an advantage for Philips right now in the market as the only FDA...

Dr. Bruce Friedman over at Lab Soft News has an interesting post today on "The "Why" and "How" of Academic Tweeting". Many of you know that Bruce is widely considered the grandfather of pathology informatics, coining the term decades ago,...